| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,721 | 1,611 | 1,405 | 2,136 | | Cost of Revenue | 1,264 | 1,430 | 1,315 | 1,876 | | | Gross Profit | 457 | 180 | 90 | 260 | | | Operating Expenses | | Research Development | 434 | 381 | 404 | 466 | | Selling General and Administrative | 913 | 1,051 | 1,000 | 1,025 | | Non Recurring |
-
|
-
| 794 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (890) | (1,252) | (2,108) | (1,230) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16 | 26 | 20 | (607) | | Earnings Before Interest And Taxes | (874) | (1,226) | (2,088) | (1,837) | | Interest Expense | 2 | 12 | 21 | 30 | | Income Before Tax | (876) | (1,239) | (2,109) | (1,867) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (876) | (1,239) | (2,109) | (1,867) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (876) | (1,239) | (2,109) | (1,867) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($876) | ($1,239) | ($2,109) | ($1,867) |
|
0.31% Nasdaq 0.00%
Income Statement
